期刊文献+

重复经颅磁刺激联合帕罗西汀治疗强迫症的对照研究 被引量:14

Treating refractory obsessive compulsive disorder with combination of paroxetine and repetitive transcranial magnetic stimulation: a double-blind sham controlled study
原文传递
导出
摘要 目的 观察重复经颅磁刺激(rTMS)合并帕罗西汀治疗难治性强迫症患者的疗效和不良反应.方法 被试入组后根据随机数字表随机分配到联合治疗组(rTMS+帕罗西汀)和药物治疗组(伪rTMS+帕罗西汀).帕罗西汀用量为20~60mg/d,起始剂量20mg/d,在2周内渐增至40~60mg/d.联合治疗组治疗时使用rTMS真刺激.刺激部位为右侧背外侧额叶,刺激频率为10HZ,刺激强度为100%运动阈值.药物治疗组治疗时使用rTMS伪刺激.观察疗效6周.采用Yale-Brown强迫症量表(Y-BOCS)、汉密尔顿焦虑量表评定疗效,以药物治疗中需处理的副作用症状量表(TESS)评估不良反应.结果 帕罗西汀+rTMS组患者痊愈9(32.14%)例,显著进步10例(35.71%),好转5例(17.86%),无变化4例(14.29%);帕罗西汀+伪rTMS组痊愈4例(16.36%),显著进步5例(21.82%),好转10例(38.18%),无效6例(23.64%),2组差异有统计学显著性(Z=2.010,P=0.044).意向分析结果表明,2组治疗均有效,Y-BOCS评分(F=56.258,P=0.000);HAMA评分(F=41.675,P=0.000).但联合治疗组效果优于药物治疗组,Y-BOCS评分(F=13.652,P=0.028);HAMA评分(F=11.632,P=0.031).结论 右侧额叶背外侧rTMS刺激联合帕罗西汀治疗难治性强迫症的疗效优于单纯帕罗西汀治疗. Objective To study the efficacy of repetitive transcranial magneticstimulation(rTMS) of the right prefrontal cortex combined paroxetine for patients with obsessive-compulsive disorder ( OCD) under doubleblind , sham-controlled conditions. Methods Patients were randomly assigned to 2 sessions of real ( n = 32) or sham ( n = 31) rTMS and both group received Paroxetine treatment. rTMS treatments lasted 20 minutes,and the frequency was 10 Hz and the intensity was 100% of motor threshold for real rTMS. Psychopathology was assessed by HAMA.Y-BOCS before the treatment,immediately after the experimental treatment,and 1,2,4,6 weeks after the experimental treatment by an independent reviewer. Results In combined therapy group,9(32. 14% ) recovered, 10(35.71% ) remitted,5( 17. 86% ) improved,4( 14. 29% ) remained unresponsive. In contrast,there were 4(16.36%) recovery,5(21.82%) remission, 10(38.18% ) improvement,6(23.64% ) unresponse in drug therapy group. The outcome of ITT showed all the patients in the two groups significant improvement (the scores of YBOCS( F=56.258, P=0.000) ;the scores of HAMA( F=41.675, P=0.000) after the treatment,but the effectiveness in the combined therapy group was better than that in the drug therapy group (the scores of Y-BOCS, F= 13.652, P=0.028;the scores of HAMA, F= 11.632, P=0.031). Conclusions Repetitive transcranial rTMS of the right prefrontal cortex combined paroxetine is more effective than paroxetine only in treatment of refractory OCD.
出处 《中华行为医学与脑科学杂志》 CAS CSCD 北大核心 2010年第7期604-606,共3页 Chinese Journal of Behavioral Medicine and Brain Science
关键词 强迫症 难治性 重复经颅磁刺激 帕罗西汀 Obsessive compulsive disorder Refractory Repetitive transcranial magnetic stimulation Proxetine
  • 相关文献

参考文献15

  • 1Husted DS,Shapira NA.A review of the treatment for refractory ob-sessive-compulsive:from medicine to deep brain stimulation.CNS Spectr,2004,9:833-847.
  • 2Hollander E,Kaplan A,Allen A,et al.Pharmacotherapy for obsessivecompulsive disorder.Psychiatry Clin North Am,2000,23:643-656.
  • 3周云飞,张亚林.难治性强迫症研究进展[J].中国神经精神疾病杂志,2004,30(6):477-478. 被引量:26
  • 4喻东山.强迫症治疗的新进展[J].中华精神科杂志,2005,38(1):50-52. 被引量:65
  • 5Greenberg BD,Ziemann U,Harmon A,et al.Decreased neuronal inhi-bition in cerebral cortex in obsessive-compulsive disorder on transcra-nial magnetic stimulation.Lancet,1998,352:881 -882.
  • 6Greenberg B,George MS,Martin JD,et al.Effects of prefrontal repeti-tive transcranial magnetic stimulation (rTMS) in obsessive-compulsive disorder:a preliminary study.Am J Psychiatry,1997,154:867-869.
  • 7张一,孟凡强,崔玉华,甘向东,郭伟.修改耶鲁—布朗强迫量表的临床信度和效度研究[J].中国心理卫生杂志,1996,10(5):205-207. 被引量:89
  • 8Sachdev PS,McBride R,Loo CK,et al.Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder:a preliminary investigation.J Clin Psychiatry,2001,62:981-984.
  • 9Alonso P,Pujol J,Cardoner N,et al.Right prefrontal repetitive tran-scranial magnetic stimulation in obsessive-compulsive disorder:a double-blind,placebo-controlled study.Am J Psychiatry,2001,158:1143-1145.
  • 10Mantovani A,Lisanby SH,Pieraecini F,et al.Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS).Int J Neuropsychopharmacol,2006,9:95-100.

二级参考文献26

  • 1Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am, 2000, 23:563-586.
  • 2Richelson E. Preclinical pharmacology of neuroleptics: focus on new generation compounds. J Clin Psychiatry, 1996, 57 Suppl 11:4-11.
  • 3Gabriels L, Cosyns P, Nuttin B, et al. Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopa-thological and neuropsychological outcome in three cases. Acta Psychiatr Scand, 2003, 107:275-282.
  • 4Flament MF, Bisserbe JC. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies. J Clin Psychiatry, 1997, 58 Suppl 12:18-22.
  • 5Hollander E, Kaplan A, Allen A, et al. Pharmacotherapy for obsessive-compulsive disorder. Psychiatr Clin North Am, 2000, 23:643-656.
  • 6Gorman JM, Kent JM. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression. J Clin Psychiatry, 1999, 60 Suppl 4:33-38.
  • 7Hollander E, Bienstock CA, Koran LM, et al. Refractory obsessive-compulsive disorder: state-of-the-art treatment. J Clin Psychiatry, 2002, 63 Suppl 6:20-29.
  • 8McDougle CJ. Update on pharmacologic management of OCD: agents and augmentation. J Clin Psychiatry, 1997, 58 Suppl 12:11-17.
  • 9Pigott TA. Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry, 1999, 60 Suppl 18:4-15.
  • 10Stein DJ. Advances in the neurobiology of obsessive-compulsive disorder:implications for conceptualizing putative obsessive-compulsive and spectrum disorders. Psychiatr Clin North Am, 2000, 23:545-562.

共引文献172

同被引文献97

引证文献14

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部